CFS Investment Advisory Services, LLC
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1845688
TOTOWA, NJ
Position in ESPR
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$77,581
+$77,581 QoQ
Shares Held
24,551
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#17
of 40 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CFS Investment Advisory Services, LLC holds $77,581 across 1 Drug Manufacturers - Specialty & Generic name. ESPR ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ESPR |
Esperion Therapeutics, Inc.
This page
|
24,551 | $77,581 |
All Filings in ESPR
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,581 | 24,551 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | — | 24,551 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | — | 24,551 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | — | 24,551 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | — | 24,551 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | — | 24,551 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | — | 24,551 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | — | 24,551 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | — | 24,551 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | — | 24,551 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | — | 24,551 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | — | 24,551 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | — | 24,551 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | — | 24,551 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | — | 24,551 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||